Medscape47m
Two Lung Cancer Drugs Recommended by EMA
Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.
Medscape40m
Leqembi Okayed for Subset of Early Alzheimer’s Patients
The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...
Merck receives CHMP opinion recommending approval of Keytruda
Merck (MRK) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP, adopted an opinion ...
The Pharma Letter14m
EMA/CHMP November recommendations include Leqembi U-turn
The European Medicines Agency’s (EMA) human medicines committee (CHMP) made a number of recommendations at its November ...
Trump’s RFK Pick Weighs on Vaccine Makers
Kennedy, a vaccine skeptic, has promised sweeping changes to food and drug regulation and government-funded scientific ...
Future Market Insights5m
Dry Powder Inhaler Market to Reach USD 29.95 Billion by 2034, Growing at a 3.70% CAGR
The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...
Ipsen Pharma: Iqirvo (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...